Recent Advances in Multiple Myeloma: Highlights from the IMS 2022 Meeting and Beyond - Episode 5

Treating Patients with High-Risk NDMM

, , , ,

The panel explains their opinions on induction therapy approaches for high-risk and standard-risk patients with NDMM.